Systematic exploration of synergistic drug pairs
Open Access
- 1 January 2011
- journal article
- research article
- Published by Springer Science and Business Media LLC in Molecular Systems Biology
- Vol. 7 (1), 544
- https://doi.org/10.1038/msb.2011.71
Abstract
Drug synergy allows a therapeutic effect to be achieved with lower doses of component drugs. Drug synergy can result when drugs target the products of genes that act in parallel pathways (‘specific synergy’). Such cases of drug synergy should tend to correspond to synergistic genetic interaction between the corresponding target genes. Alternatively, ‘promiscuous synergy’ can arise when one drug non‐specifically increases the effects of many other drugs, for example, by increased bioavailability. To assess the relative abundance of these drug synergy types, we examined 200 pairs of antifungal drugs in S. cerevisiae. We found 38 antifungal synergies, 37 of which were novel. While 14 cases of drug synergy corresponded to genetic interaction, 92% of the synergies we discovered involved only six frequently synergistic drugs. Although promiscuity of four drugs can be explained under the bioavailability model, the promiscuity of Tacrolimus and Pentamidine was completely unexpected. While many drug synergies correspond to genetic interactions, the majority of drug synergies appear to result from non‐specific promiscuous synergy.This publication has 32 references indexed in Scilit:
- Quantitative analysis of fitness and genetic interactions in yeast on a genome scaleNature Methods, 2010
- Chemical combinations elucidate pathway interactions and regulation relevant to Hepatitis C replicationMolecular Systems Biology, 2010
- Nonoptimal Microbial Response to Antibiotics Underlies Suppressive Drug InteractionsCell, 2009
- Synergistic drug combinations tend to improve therapeutically relevant selectivityNature Biotechnology, 2009
- Drug interactions and the evolution of antibiotic resistanceNature Reviews Microbiology, 2009
- Chemogenomic profiling predicts antifungal synergiesMolecular Systems Biology, 2009
- Models from experiments: combinatorial drug perturbations of cancer cellsMolecular Systems Biology, 2008
- Chemical combination effects predict connectivity in biological systemsMolecular Systems Biology, 2007
- Functional classification of drugs by properties of their pairwise interactionsNature Genetics, 2006
- Integration of chemical-genetic and genetic interaction data links bioactive compounds to cellular target pathwaysNature Biotechnology, 2003